Note: The Entyvio HCP site calls UC Trials I and II of the Prescribing Information the GEMINI I trial. Table 4 columns are placebo (N=149), ENTYVIO IV 300 mg (N=225), p-value, and treatment difference with 95% CI, in that order.
What were Entyvio IV Week 52 results in ulcerative colitis (GEMINI I)?
Applies to Moderately to severely active ulcerative colitis in adults, intravenous induction and maintenance
Note: Only patients in clinical response at Week 6 after two ENTYVIO IV doses were randomized. Table 5 columns are placebo (N=126), ENTYVIO IV 300 mg every 8 weeks (N=122), p-value, and treatment difference with 95% CI, in that order; the every-4-week arm is not shown.
Does Entyvio help ulcerative colitis patients get off steroids (GEMINI I)?
Applies to Moderately to severely active ulcerative colitis in adults, intravenous induction and maintenance
Note: Values are placebo (14%), ENTYVIO IV 300 mg every 8 weeks (31%), p-value, and treatment difference with 95% CI, at Week 52 in UC Trial II, in that order.
How well does subcutaneous Entyvio work for ulcerative colitis (VISIBLE 1)?
Applies to Moderately to severely active ulcerative colitis in adults, subcutaneous maintenance after two intravenous induction doses
Note: The Prescribing Information calls VISIBLE 1 the SC UC Trial (NCT02611830). Within each row of Table 6, the placebo N and percentage come first, then the ENTYVIO 108 mg subcutaneous every 2 weeks N and percentage, then the estimated treatment difference with 95% CI for the total population. The 64% versus 20% figure is for the subgroup in remission at Week 6; the efficacy page reports durable clinical remission for the overall population.
Comparative studies
Entyvio vs Humira: which had higher ulcerative colitis remission at Week 52 (VARSITY)?
Applies to Moderately to severely active ulcerative colitis in adults, intravenous induction and maintenance
Note: The page labels the VARSITY comparison ENTYVIO IV vs Humira (adalimumab). The page states the endoscopic improvement and corticosteroid-free remission results without percentages and does not state which arm had the higher corticosteroid-free remission rate.
Outcome measures
How is ulcerative colitis remission defined in Entyvio trials (Mayo score)?